Framework Agreement for the provision of a Homecare service for Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies

The provision of a dispensing/compounding and delivery service to patients' homes for Parenteral Chemotherapy plus associated treatments and for Parenteral Biologics plus nursing support for administration for all products. Current Acute Membership is listed below but is subject to change throughout the life of any resulting contract. The following web address provides the most up to date member list. https://www.empc.nhs.uk/ The Purchasing Collaborative Organisations that are listed under The Specialist Pharmacy Service may participate in this Framework during the Contract period. Please see the current list at: https://www.sps.nhs.uk/articles/collaborative-purchasing-organisations/ Framework agreement may extend to: All National Health Service (NHS) bodies in England, including but not limited to: NHS Provider Directory: https://www.england.nhs.uk/publication/nhs-provider-directory/ NHS Foundation Trusts at: https://www.england.nhs.uk/wp-content/uploads/2019/04/Public_Registry_FT_directory_190403.xls This is a two-year contract with the option to extend for a further 2 years at the discretion of the EMPC and provider(s) agreement. Additional information: This is a two-year contract with the option to extend for a further 2 years at the discretion of the EMPC and provider(s) agreement. The current annual value of the contract for The East Midlands Pharmacy Collaborative Members (EMPC) is £32m. We anticipate growth of this Contract with additional Trust take up and increase in patient numbers. The anticipated contract value over a 4 year period is in the region of £450m; depending on Contract take up by the Trusts listed in 11.2.4 Suppliers will be required to meet the NHS Data Security and Protection Toolkit Standard for their Information Systems